Abstract
Objective
To investigate the effect of norepinephrine (NE) on hemodynamics, oxygen metabolism and renal function in patients with severe septic shock.
Design
Prospective study.
Setting
Post-operative ICU in a municipal general hospital.
Patients
The study included 56 patients with extreme low resistance states due to abdominal sepsis, who remained hypotensive (MAP<60 mmHg) despite optimal fluid therapy and dopamine>20μg/kg/min and cumulative doses of dopamine and dobutamine>30μg/kg/min, respectively.
Interventions
After registration of baseline values dopamine was reduced to 2.5μg/kg/min, and norepinephrine was administered starting at a dose of 0.05 μg/kg/min until a mean arterial pressure of more than 60 mmHg could be maintained.
Measurements and results
During norepinephrine infusion (dosage ranging between 0.1–2μg/kg/min, mean dose rate: 0.4μg/kg/min) mean arterial pressure and systemic vascular resistance index increased significantly (p<0.001). After 8h a significant increase in stroke volume (p<0.05) and decrease in heart rate (P<0.05) could be observed. There was no significant change in cardiac index (CI), oxygen delivery (O2AVI) and oxygen consumption (VO2I). Creatinine clearance increased significantly (p<0.005) from a control value of 75±37 ml/min to 102±43 ml/min after 48 h NE-trearment.
Conclusion
Our results suggest that norepinephrine can be used safely in the treatment of severe septic shock states. Mean arterial pressure and glomerular filtration rate improved markedly without deleterious effects on CI, O2AVI and VO2I.
Similar content being viewed by others
References
Shoemaker WC (1987) Circulatory mechanisms of shock and their mediators. Crit Care Med 15:787–794
Thijs LG (1988) Transport and consumption of oxygen in septic shock. In: Vincent JL (ed) Update inmintensive care and emergency medicine, Springer, Berlin Heidelberg New York, pp 44–50
Vincent JL, De Backer D (1989) Initial management of circulatory shock as prevention of MSOF. Crit Care Clin 5:369–378
Abraham E, Shoemaker WC, Bland RD, Cobo JC (1983) Sequential cardiorespiratory patterns in septic shock. Crit Care Med 11:799–803
Astiz ME, Rackow EC, Falk JL, Kaufmann BS, Weil MH (1987) Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 15:26–28
Edwards JD, Brown GCS, Nightingale P, Slater RM, Faragher EB (1989) Use of survivors' cardiorespratory values as therapeutic goals in septic shock. Crit Care Med 17:1098–1103
Shoemaker WC, Appel PL, Waxman K, Schwartz S, Chang P (1982) Clinical trial of survivors' candiorespiratory patterns as therapeutic goals in critically ill postoperative patients. Crit Care Med 10:398–403
Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD (1987) A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 15:134–137
Baumgartner JD, Vaney C, Perret C (1984) An extreme form of the hyperdynamic syndrome in septic thock. Intensive Care Med 10:245–249
Groeneveld ABJ, Bronsveld W, Thijs LG (1986) Hemodynamic determinants of mortality in human septic shock. Surgery 99:140–152
Natanson C, Hoffmann WD, Parillo IE: Septic shock (1989) The cardiovascular abnormality and therapy. J Cardiothoracic Anesth 3:215–227
Parker MM, Shelhamer JH, Natanson C, Masur H, Parillo JE (1984) Serial hemodynamic patterns in survivors and nonsurvivors of septic shock in humans. Crit Care Med 12:311
Melchior JC, Pinaud M, Blanloeil Y, Bourelli B, Potel G, Souron R (1987) Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shock. Crit Care Med 15:687–691
Hesselvik JF, Brodin B (1989) Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 17:179–180
Martin C, Saux P, Albanese J, Bonneru JJ, Gouin F (1987) A new look at norepinephrine to treat human hyperdynamic septic shock. Anesthesiology 87:A648
Meadows D, Edwards JD, Wilkins RG, Nightingale P (1988) Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16:663–666
Wciner N (1980) Norepinephrine, epinephrine and the sympathomimetic amines. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, p 138
Cronin RE, De Torrente A, Miller PD, Bulger RE, Burke TJ, Schrier RW (1978) Pathogenic mechanisms in early norepinephrineinduced acute renal failure: functional and histological correlates of protection. Kidney Int 14:115–125
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1989) The methylprednisolone severe sepsis study group. Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389–393
Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13:818–829
Zadrobilek E, Hackl W, Sporn P, Steinbereithner K (1989) Effect of large volume replacement with balanced electrolyte solutions on extravascular lung water in surgical patients with sepsis syndrome. Intensive Care Med 15:505–510
Sporn P, Edelmann G, Hackl W, Kolacny M, Mauritz W, Redl-Wenzl EM, Redl G, Wechsler-Fördös A, Zadrobilek E (1989) Akntes Nierenversagen bei abdomineller Sepsis. In: Sporn P, Mauritz W, Hackl W, Bergmann H (eds) Die abdominelle Katastrophe. Maudrich, Wien München Bern, pp 161–162
Schaer GL, Fink MP, Parillo JE (1985) Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressure therapy. Crit Care Med 13: 492–496
Mills LC, Moyer JF, Handley CA (1960) Effects of various sympathicomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 198:1279–1283
Martin C, Eon B, Saux P, Aknin P, Gouin F (1989) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18:282–285
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Redl-Wenzl, E.M., Armbruster, C., Edelmann, G. et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19, 151–154 (1993). https://doi.org/10.1007/BF01720530
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720530